A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
267
Participants
Timeline
Start Date
December 31, 2000
Study Completion Date
May 31, 2002
Conditions
Bipolar DisordersManic Episode
Interventions
DRUG
Risperidone, oral tablets
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00257075 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder | Biotech Hunter | Biotech Hunter